ULTRA REJUVE 7S AMPOULE (GLYCERIN) LIQUID [ULAB]

ULTRA REJUVE 7S AMPOULE (GLYCERIN) LIQUID [ULAB]
PDF | XML

NDC 71276-120-01, 71276-120-02
Set ID 643f64bd-0b9d-43e5-95e4-0208a192c093
Category HUMAN OTC DRUG LABEL
Packager ULAB
Generic Name
Product Class
Product Number
Application Number
  • ACTIVE INGREDIENT

    Active ingredients: GLYCERIN 0.97%

  • INACTIVE INGREDIENT

    Inactive ingredients: AQUA (WATER), PROPYLENE GLYCOL, PANTHENOL, PENTYLENE GLYCOL, PHENOXYETHANOL, HYDROLYZED WHEAT PROTEIN, CAPRYLYL/CAPRYL GLUCOSIDE, CENTELLA ASIATICA EXTRACT, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, PARFUM (FRAGRANCE), SACCHAROMYCES LYSATE, DISODIUM EDTA, TRITICUM VULGARE (WHEAT) SEED EXTRACT, ALGAE EXTRACT, SODIUM HYDROXIDE, o-CYMEN-5-OL, ETHYLHEXYLGLYCERIN, DISODIUM SUCCINATE, GLUTAMIC ACID, GLYCINE, THREONINE, VALINE, CITRIC ACID, POTASSIUM SORBATE, SODIUM BENZOATE, CI 19140 (FD&C YELLOW N°5)

  • PURPOSE

    Purpose: Skin rebalancing and nourishing

  • WARNINGS

    Warnings: For external use only Avoid contact with eyes. Discontinue use if signs of irritation or rashes appear.

  • KEEP OUT OF REACH OF CHILDREN

    KEEP OUT OF REACH OF CHILDREN

  • INDICATIONS & USAGE

    Indications & Usage: Apply morning and night

  • DOSAGE & ADMINISTRATION

    Dosage & Administration: Apply morning and night on clean face and neck prior to moisturizers

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    Image of carton

  • INGREDIENTS AND APPEARANCE
    ULTRA REJUVE 7S AMPOULE 
    glycerin liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71276-120
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN0.04 g  in 5 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71276-120-025 in 1 CARTON03/02/2017
    1NDC:71276-120-015 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other03/02/2017
    Labeler - ULAB (688976692)
    Registrant - ULAB (688976692)
    Establishment
    NameAddressID/FEIBusiness Operations
    ULAB688976692relabel(71276-120)
    Establishment
    NameAddressID/FEIBusiness Operations
    U-LAB Switzerland AG485958743manufacture(71276-120)

Related Drugs